Alexsia Richards

Abstract Although respiratory symptoms are the most prevalent disease manifestation of infection by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), nearly 20% of hospitalized patients are at risk for thromboembolic events. This prothrombotic state is considered a key factor in the increased risk of stroke, which has been observed clinically during both acute infection and long after symptoms have cleared.

1 Introduction Association between Zika virus (ZIKV) infection, pregnancy complications, and congenital neurodevelopmental disorders like microcephaly declared ZIKV a global public health threat (1). Although ZIKV is predominantly transmitted to humans by mosquitoes, accumulating evidence indicates that ZIKV is also capable of transmission via blood transfusions, sexual, or congenital routes (2).

New Results doi: https://doi.org/10.1101/2023.01.10.523422 Abstract COVID-19 has impacted billions of people in the world since 2019 and unfolded a major healthcare crisis. With an increasing number of deaths and the emergence of more transmissible variants, it is crucial to better understand the biology of the disease-causing virus, the SARS-CoV-2. Peripheral neuropathies appeared as a specific COVID-19 symptom occurring at later stages of the disease.